Centre Testing Intl Shenzhen Market Cap ($3.80 Billion)
Market Cap & Net Worth: Centre Testing Intl Shenzhen (300012)
Centre Testing Intl Shenzhen market cap. Centre Testing Intl Shenzhen (SHE:300012) has a market capitalization of $3.80 Billion (CN¥25.97 Billion) as of October 31, 2026. Listed on the SHE stock exchange, this China-based company holds position #4114 globally and #557 in its home market, demonstrating a 3.28% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Centre Testing Intl Shenzhen's stock price CN¥15.43 by its total outstanding shares 1682828214 (1.68 Billion).
Centre Testing Intl Shenzhen Market Cap History (2015–2026)
Centre Testing Intl Shenzhen market cap history from 2015 to 2026. Data shows growth from $1.46 Billion to $3.80 Billion (11.30% CAGR). Check 300012 stock price for real-time trading data and today's change.
Index Memberships
Centre Testing Intl Shenzhen is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
ChiNext
CNT
|
$883.19 Billion | 0.43% | #56 of 100 |
Weight: Centre Testing Intl Shenzhen's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Centre Testing Intl Shenzhen Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Centre Testing Intl Shenzhen's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Also see Centre Testing Intl Shenzhen (300012) cash flow conversion for how efficiently the company converts equity into cash flow.
Latest Price to Sales (P/S) Ratio
0.50x
Centre Testing Intl Shenzhen's market cap is 0.50 times its annual revenue
Latest Price to Earnings (P/E) Ratio
3.28x
Centre Testing Intl Shenzhen's market cap is 3.28 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $1.38 Billion | $1.65 Billion | $101.54 Million | 0.83x | 13.57x |
| 2017 | $1.07 Billion | $2.12 Billion | $133.90 Million | 0.51x | 7.99x |
| 2018 | $1.58 Billion | $2.68 Billion | $269.98 Million | 0.59x | 5.85x |
| 2019 | $3.61 Billion | $3.18 Billion | $476.40 Million | 1.13x | 7.57x |
| 2020 | $6.64 Billion | $3.57 Billion | $577.61 Million | 1.86x | 11.49x |
| 2021 | $6.52 Billion | $4.33 Billion | $746.19 Million | 1.51x | 8.74x |
| 2022 | $5.43 Billion | $5.13 Billion | $902.73 Million | 1.06x | 6.01x |
| 2023 | $3.47 Billion | $5.60 Billion | $910.20 Million | 0.62x | 3.81x |
| 2024 | $3.06 Billion | $6.08 Billion | $921.07 Million | 0.50x | 3.32x |
| 2025 | $3.34 Billion | $6.62 Billion | $1.02 Billion | 0.50x | 3.28x |
Competitor Companies of 300012 by Market Capitalization
Companies near Centre Testing Intl Shenzhen in the global market cap rankings as of October 31, 2026. See Centre Testing Intl Shenzhen (300012) balance sheet quality index to understand what proportion of total assets are financed by equity.
Key companies related to Centre Testing Intl Shenzhen by market ranking:
- Cintas Corporation (NASDAQ:CTAS): Ranked #337 globally with a market cap of $80.31 Billion USD.
- Thomson Reuters Corp (TO:TRI): Ranked #525 globally with a market cap of $51.82 Billion USD ( CA$71.64 Billion CAD).
- Copart Inc (NASDAQ:CPRT): Ranked #913 globally with a market cap of $29.02 Billion USD.
- Global Payments Inc (NYSE:GPN): Ranked #1129 globally with a market cap of $22.79 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #337 | Cintas Corporation | NASDAQ:CTAS | $80.31 Billion | $219.82 |
| #525 | Thomson Reuters Corp | TO:TRI | $51.82 Billion | CA$165.36 |
| #913 | Copart Inc | NASDAQ:CPRT | $29.02 Billion | $30.13 |
| #1129 | Global Payments Inc | NYSE:GPN | $22.79 Billion | $96.84 |
Market Capitalization of Centre Testing Intl Shenzhen (2015–2026)
Market capitalization of Centre Testing Intl Shenzhen from 2015 to today. Between 2015 and today, Centre Testing Intl Shenzhen's market cap moved from $1.46 Billion to $ 3.80 Billion, with a yearly change of 11.30%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥3.80 Billion | +13.87% |
| 2025 | CN¥3.34 Billion | +9.01% |
| 2024 | CN¥3.06 Billion | -11.72% |
| 2023 | CN¥3.47 Billion | -36.12% |
| 2022 | CN¥5.43 Billion | -16.76% |
| 2021 | CN¥6.52 Billion | -1.72% |
| 2020 | CN¥6.64 Billion | +83.92% |
| 2019 | CN¥3.61 Billion | +128.51% |
| 2018 | CN¥1.58 Billion | +47.59% |
| 2017 | CN¥1.07 Billion | -22.38% |
| 2016 | CN¥1.38 Billion | -5.60% |
| 2015 | CN¥1.46 Billion | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2026 the market cap of Centre Testing Intl Shenzhen was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $3.80 Billion USD |
| MoneyControl | $3.80 Billion USD |
| MarketWatch | $3.80 Billion USD |
| marketcap.company | $3.80 Billion USD |
| Reuters | $3.80 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Centre Testing Intl Shenzhen
Centre Testing International Group Co. Ltd. provides testing, inspection, certification, calibration, audit, training, and technical services in China and internationally. It operates in five segments: Trade Protection; Consumer Product Testing; Industrial Testing; Life Sciences; and Pharmaceuticals and Medical Services. The company offers environmental protection and regulatory; in-vehicle elect… Read more